Ethics and regulatory complexities for pragmatic clinical trials.
about
Why Most Clinical Research Is Not UsefulPractical clinical trials in psychopharmacology: a systematic reviewResearch ethics committees in the regulation of clinical research: comparison of Finland to England, Canada, and the United States.Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015Electronic health records to facilitate clinical research.Pragmatic Clinical Trials in CKD: Opportunities and ChallengesGoal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays"Targeted" consent for pragmatic clinical trialsDigoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortEthical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.Harmonization and streamlining of research oversight for pragmatic clinical trialsHarms, benefits, and the nature of interventions in pragmatic clinical trials.The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.Blood Pressure Visit Intensification Study in Treatment: Trial design.Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet)Oversight on the borderline: Quality improvement and pragmatic research.Is Shared Decision Making an Appropriate Analytic Frame for Research on Medical Practices?Ethics and Regulatory Challenges and Opportunities in Patient-Centered Comparative Effectiveness Research.How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesExploring the ethical and regulatory issues in pragmatic clinical trials.Patients' Views Concerning Research on Medical Practices: Implications for Consent.Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia.Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.Anticipated Ethics and Regulatory Challenges in PCORnet: The National Patient-Centered Clinical Research Network.Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey.A Proposed Process for Reliably Updating the Common Rule.A comparison of institutional review board professionals' and patients' views on consent for research on medical practices.The Cumulative Burden of Mental, Substance Use, and General Medical Disorders and Rehospitalization and Mortality After an Injury.Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients.Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.Patients' beliefs regarding informed consent for low-risk pragmatic trials.Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research.A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.Is it important to disclose how treatments are selected in clinical research and clinical care?A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
P2860
Q24707972-A91138A5-85BF-466F-B812-EE8D51C8EC53Q27021467-6D38BFEC-F66D-4389-8ADD-97BE1BB0098AQ27303838-F148B57B-CEC4-44D5-952C-E94C3BAC390AQ27332116-37AAF235-78CB-4381-B0C7-DC76DFC57672Q28603731-4B9B1406-25E5-4C83-A12C-1A72C020E8C8Q30248321-F9E206A7-1788-4B44-AD14-730ECE9FC183Q30249723-1B2165BC-9080-4C04-A671-E0DDF1BD06D3Q33689210-0E75F1F8-AD7F-4855-AFBA-38CB3DCD7BABQ35396652-20EFD14C-8918-47CC-8E2C-972DA453EA4EQ35789263-2661DA3C-A4DB-40BE-BB07-12618078478BQ35838307-12BC030B-64DF-4856-AD6F-5A2425BFAAB0Q36117724-84FBD7C5-BA78-4344-9FC5-4FD2B04C4C34Q36117803-7471C6D9-FC52-46EA-B08C-14EDA2A6702DQ36326037-7493A6A2-53FA-416B-939A-259380937639Q36385560-44F9C456-9180-4A5F-BFD1-078342BE9CFDQ36407121-9F40C12B-B95F-48E4-B984-0889559BE124Q36425557-A5A0E36B-FA26-47F9-8E92-12B00883F29CQ36569748-EF418ECC-3AF3-4641-A613-ECB9FF1A4518Q36739527-02E8650A-C488-4F98-8632-3EA42BAD7127Q36877763-2691A72E-4AAB-480B-88D1-6B4B810A80B7Q36963233-97A71DB1-AB30-4E45-BEF4-F9E4C7C1B511Q37376621-0132A75C-76F8-44BC-A7B7-B3EE31023EE2Q37710165-EAD63AD0-D685-4C8F-AE4F-A934E5082A78Q38358209-E36681A4-9553-46F3-A4C8-2765BDA09E47Q38376419-847C9AB9-747D-4F2B-8519-9071A0A05786Q38550799-E66C5AE6-64F9-4C6F-9E92-4DA33C9012EDQ38555205-7781E15A-5DCF-4DCD-8C6C-25C79356C4C6Q38665110-5AB0A0C3-525E-428C-BE91-5A1E1E3499E3Q38852440-59537B4D-D7A8-416C-A6D7-EC84C1ECB788Q39112137-14BB128E-53D4-4678-8ADB-5C663E5DF229Q40362543-99254119-DA21-4D48-909D-7BDFF7E3C2D1Q41529816-5C36780B-3795-4AAF-9D9A-8D9A7AE19750Q41711992-19AC2F93-4151-497F-BF2E-DBDD3F78FFA5Q41711995-0EAA1B9C-8A56-46D6-A857-63A238A1B557Q42375084-E40933C5-49FE-466A-B9DB-E945CC692CD0Q47709698-E5AF8509-F74A-4405-BFB5-32FD70CBB54EQ47757313-947A0684-B62D-4B0E-9F86-C8E5EC76AEEAQ47839541-1EF963DF-BFE3-45EA-A0EE-6A8805670BD1Q47928731-121A6C50-14BF-4927-887C-FC9B7682DB1EQ48163223-44360608-571D-4061-9A1D-4A588F16A43C
P2860
Ethics and regulatory complexities for pragmatic clinical trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Ethics and regulatory complexities for pragmatic clinical trials.
@en
Ethics and regulatory complexities for pragmatic clinical trials.
@nl
type
label
Ethics and regulatory complexities for pragmatic clinical trials.
@en
Ethics and regulatory complexities for pragmatic clinical trials.
@nl
prefLabel
Ethics and regulatory complexities for pragmatic clinical trials.
@en
Ethics and regulatory complexities for pragmatic clinical trials.
@nl
P356
P1476
Ethics and regulatory complexities for pragmatic clinical trials.
@en
P304
P356
10.1001/JAMA.2014.4164
P407
P577
2014-06-01T00:00:00Z